Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 237-393-5 | CAS number: 13770-61-1
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
![](https://echa.europa.eu/o/diss-blank-theme/images/factsheets/A-REACH/factsheet/print_toxicological-information.png)
Repeated dose toxicity: inhalation
Administrative data
- Endpoint:
- sub-chronic toxicity: inhalation
- Type of information:
- read-across based on grouping of substances (category approach)
- Adequacy of study:
- key study
- Study period:
- No information
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Justification for type of information:
- see section 13 in IUCLID for read-across justification report
Data source
Reference
- Reference Type:
- publication
- Title:
- Two- and 13-week Inhalation Toxicities of Indium-Tin Oxide and Indium Oxide in Rats.
- Author:
- Nagano K, Gotoh K, Kasai T, Aiso S, Nishizawa T, Ohnishi M, Ikawa N, Eitaki Y, Yamada K, Arito H and Fukushima S
- Year:
- 2 011
- Bibliographic source:
- J Occup Health 53 (2)
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 413 (Subchronic Inhalation Toxicity: 90-Day Study)
- GLP compliance:
- not specified
- Limit test:
- no
Test material
- Reference substance name:
- Diindium trioxide
- EC Number:
- 215-193-9
- EC Name:
- Diindium trioxide
- Cas Number:
- 1312-43-2
- Molecular formula:
- In2O3
- IUPAC Name:
- diindium trioxide
- Details on test material:
- - Name of test material (as cited in study report): indium oxide (IO)
- Physical state: powder
- Analytical purity: 99.9%
- Impurities (identity and concentrations): trace amounts of tin, silica and lead
Constituent 1
Test animals
- Species:
- rat
- Strain:
- Fischer 344/DuCrj
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Charles River Japan, Inc (Kanagawa, Japan)
- Age at study initiation: 4 wk old
- Weight at study initiation: M: 101-104 g (mean body weight per group); F: 92-94 g (mean body weight per group)
- Housing: individually in stainless-steel wire hanging cages, which were placed in a stainless steel inhalation exposure chamber
- Diet : sterilized commercial pellet diet (CRF-1, Oriental Yeast Co., Ltd, Tokyo, Japan)
- Water : sterilized water, ad libitum
- Acclimation period: 2 wk
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 20-24
- Humidity (%): 30-70
- Air changes (per hr): 12
- Photoperiod (hrs dark / hrs light): 12/12
Administration / exposure
- Route of administration:
- inhalation: aerosol
- Type of inhalation exposure:
- whole body
- Vehicle:
- other: no data
- Mass median aerodynamic diameter (MMAD):
- >= 2.1 - <= 2.3 µm
- Geometric standard deviation (GSD):
- 1.7
- Remarks on MMAD:
- dose 0.1 mg/m3 : MMAD: 2.1 µm, GSD: 1.7µm
dose 1mg/m3: MMAD: 2.3 µm, GSD: 1.7µm - Details on inhalation exposure:
- GENERATION OF TEST ATMOSPHERE / CHAMBER DESCRIPTION
- Exposure apparatus:
for 100mg/m3 a system was used consisting of a dust feeder equiped with an ejector, an exposure chamber and a digital dust indicator (Type AP-632T, Sibata Scientific Technology, Ltd, Tokyo, Japan)
for 10, 1 and 0.1mg/m3 a system was used consisting of the first-stage system for aerosol generation of a high concentration at 100mg/m3 and a further dilution system
- System of generating particulates/aerosols:
for 100mg/m3: drawing the powder with compressed clean air at the first ejector and introduced into the top of the exposure chamber where the filtered air had been kept flowing downward at 12 air changes/h
for 10, 1 and 0.1mg/m3: aerosol generation of the high concentration and its regulation were performed in the same manner as described above, and airflow containing the aerosol was delivered to a reservoir chamber for stabilization of the aerosol concentration. The airflow containing the aerosol was delivered to the second ejector and then introduced into the top of the exposure chambers where the filtered air had been kept flowing downward at 12 air changes/h
- Method of particle size determination: particles were collected on a filter and dissolved in a mixture solution of distilled water, hydrochloric acid and nitric acid (2:2:1 by volume ratio) at 160 °C. The resulting solution was diluted with nitric acid, and then subjected to atomic absorption spectrometry analysis (Polarized Zeeman Atomic Absorption Spectrophotometer, Z-5010)
- Particle size distribution: the material aerosol was collected with an 8-stage Andersen sampler. Using the mass of the particles on the filter collected at each stage of the Andersen sampler, mass median aerodynamic diameter (MMAD) and geometric standard deviation (GSD) were determined
- Temperature, humidity, pressure in air chamber: negative pressure (-100 Pa)
TEST ATMOSPHERE
- Analytical method used: the mass-equivalent concentration of the material aerosol was monitored with the digital dust indicator; aerosol concentration in the exposure chamber was monitored with the second digital dust indicator and regulated at a target concentration of 10, 1 or 0.1 mg/m3
- Analytical verification of doses or concentrations:
- yes
- Details on analytical verification of doses or concentrations:
- none
- Duration of treatment / exposure:
- 13 wk
- Frequency of treatment:
- 6h/day, 5day/wk for 13 wk
Doses / concentrationsopen allclose all
- Dose / conc.:
- 0.1 mg/m³ air
- Dose / conc.:
- 1 mg/m³ air
- No. of animals per sex per dose:
- 10 rats of each sex per dose
- Control animals:
- yes, concurrent no treatment
- Details on study design:
- none
- Positive control:
- None
Examinations
- Observations and examinations performed and frequency:
- DETAILED CLINICAL OBSERVATIONS: Yes
- Time schedule: animals were observed daily for their clinical signs and mortality
BODY WEIGHT: Yes
- Time schedule for examinations: weekly throughout the study periods
FOOD CONSUMPTION:
- Food consumption for each animal determined : weekly throughout the study periods
HAEMATOLOGY: Yes
OTHER: sections of lung tissue were examined. - Sacrifice and pathology:
- animals surviving to the end of the 13wk received complete necropsy
- Other examinations:
- Determination of indium concentrations in the lung and blood
- Statistics:
- Body weight, organ weight, and hematological and blood biochemical parameters were analyzed by Dunnett's test. Histopathological findings in the 13 weeks study were analyzed by chi-square. A two tailed test was used for all statistics. a p value of 0.05 was used as the level of significance.
Results and discussion
Results of examinations
- Clinical signs:
- no effects observed
- Mortality:
- no mortality observed
- Body weight and weight changes:
- not examined
- Food consumption and compound intake (if feeding study):
- not examined
- Food efficiency:
- not examined
- Water consumption and compound intake (if drinking water study):
- not examined
- Ophthalmological findings:
- not examined
- Haematological findings:
- effects observed, treatment-related
- Clinical biochemistry findings:
- not examined
- Urinalysis findings:
- not examined
- Behaviour (functional findings):
- not examined
- Organ weight findings including organ / body weight ratios:
- effects observed, treatment-related
- Gross pathological findings:
- not specified
- Histopathological findings: non-neoplastic:
- effects observed, treatment-related
- Histopathological findings: neoplastic:
- not examined
- Details on results:
- CLINICAL SIGNS AND MORTALITY: neither death nor abnormal clinical sign, such as irregular sounds of respiration, was observed in any group exposed to the test material for 13 weeks. There was no growth retardation in any group exposed to the test material for 13 weeks as compared with the growth rate in the respective control.
HAEMATOLOGY: potassium was significantly decreased in both 0.1 and 1 mg/m3 indium oxide exposed rats. Significant decreases in sodium and chlorine in the 0.1 and 1 mg/3 indium oxide exposed rats and significantly decreased triglyceride in the 0.1 and 1 mg/m3 indium oxide exposed female rats were also observed.
ORGAN WEIGHTS: significantly increased relative lung weights in the rats of both sexes exposed to indium oxide at 0.1 and 1 mg/m3
HISTOPATHOLOGY: NON-NEOPLASTIC:
-test material particles were deposited in the lung of all the exposed rats , primarly within the alveolar macrophages and partly as a free form in the alveolar space. The test material particles were also observed to a lesser extent in the bronchus-associated lymhoid tissue (BALT) of the lung of 1mg/m3 indium oxide exposed rats, in the mediastinal lymph nodes (MLN) of both 0.1 and 1mg/m3 indium oxide exposed rats and in the nasal-associated lymphoid tissue (NALT) of the nasopharyngeal duct of the 1mg/m3 indium oxide exposed rats
- significant increase of alveolar proteinosis in the 1 mg/m3 indium oxide exposed rats
- incidences of alveolar macrophage infiltration were significantly increased in the 0.1 and 1mg/m3 indium oxide exposed rats
- significant infiltration of inflammatory cells was observed in the 1 mg/m3 indium oxide exposed rats
- significant increase hyperplasia of alveolar epithelium occured in the 1mg/m3 indium oxide exposed rats
Effect levels
open allclose all
- Dose descriptor:
- LOAEL
- Effect level:
- 1 mg/m³ air
- Based on:
- test mat.
- Sex:
- male/female
- Basis for effect level:
- organ weights and organ / body weight ratios
- other: lung effects
- Dose descriptor:
- NOAEL
- Effect level:
- 0.1 mg/m³ air
- Based on:
- test mat.
- Sex:
- male/female
- Remarks on result:
- other: The only effects are: infiltration of alveolar macrophage and neutrophils, increased lung weight. The 0.1 mg/m3 dose level shows an adaptive response to the clearance of a relatively insoluble metallic salt and could therefore be defined as a NOAEL
Target system / organ toxicity
- Critical effects observed:
- yes
- Lowest effective dose / conc.:
- 1 mg/m³ air
- System:
- respiratory system: lower respiratory tract
- Organ:
- alveoli
- bronchi
- bronchioles
- lungs
- Treatment related:
- yes
- Dose response relationship:
- yes
- Relevant for humans:
- yes
Any other information on results incl. tables
Lung and blood contents of indium: -) lung contents of indium were increased with an increase in the concentration of exposure to indium oxide or indium tin oxide: -the exposure concentration related increase in the whole lung content of indium was disproportionally lowered to greater extent in the indium tin oxide exposed rats than in the indium oxide exposed rats. -the whole lung contents of indium in the 0.1 mg/m3 indium tin oxide exposed rats of both sexes were higher than those of the 0.1mg/m3 indium oxide exposed rats of both sexes. -the whole lung contents of indium in the indium tin oxide exposed rats of both sexes measured at the end of the 26 wk post exposure period were lowered to 40% as compared with those measured at the end of the 13 wk exposure -) the blood contents of indium in the 1mg/m3 indium tin oxide exposed groups of both sexes were 4 -fold higher than those in 1mg/m3 indium oxide group of both sexes. The blood contents of indium in the 0.1 mg/m3 indium tin oxide exposed rats of both sexes measured at the end of the 26 week post exposure period were 1.3 fold higher than those measured at the end of the 13 week exposure period.
Applicant's summary and conclusion
- Conclusions:
- Persistent pulmonary lesions including alveolar proteinosis and macrophage infiltration occured after 13 wk inhalation exposure of F344 rats to indium oxide.
In this study the rats were also administered by inhalation indium tin oxide and the results indicate that the pulmonary toxicity of inhaled indium tin oxide particles is more severe than that of indium oxide particles and that alveolar macrophages play a critically important role in the induction of indium toxicity as evidenced by alveolar proteinosis, alveolar macrophage infiltration and swollen alveolar macrophages engulfing the particles, all of which occur at the lowest exposure concentration of 0.1 mg/m3 indium tin oxide. - Executive summary:
A study was conducted to determine the effects of sub-chronic exposure of the test material on the respiratory system in F344 rats.
The test material was administered by inhalation 6 h /d and 5 d/wk for 13 wk at 0, 0.1 or mg/m3 to groups of 10 rats/sex/dose. Blood and lung contents of indium were elevated in a dose-related manner in the indium oxide exposed rats. The indium oxide particles were deposited in the lung, mediastianl lymph node and nasal-associated lymphoid tissue. Exposures to the test material induced alveolar proteinosis, infiltrations of alveolar macrophages and inflammatory cells and alveolar epithelial hyperplasia in addition to increased lung weight.
In conclusion, persistent pulmonary lesions including alveolar proteinosis and macrophage infiltration occured after 13 wk inhalation exposure of rats to indium oxide.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
![ECHA](/o/diss-blank-theme/images/factsheets/A-REACH/factsheet/echa_logo.png)